Registration is closed

AAADV not only impacts the rate at which oncology drugs are brought to market, but patients afflicted with cancer have been able to appreciate significant advances in their care and survival rates.

Richard Pazdur

Director, Office of Hematology and Oncology Drug Products

U.S. Food and Drug Administration Center for Drug Evaluation and Research


14th Annual AAADV Workshop

Leaders in clinical and translational cancer research from academic, industry, government and the nonprofit advocacy sector focus on understanding and efficiently negotiating the drug development process.

May 3-5, 2017

Enroll Now


Workshop 2016 Gallery



Download AAADV Mobile app for Android and iOS

app-store-image google-play-image